CRDL
Cardiol Therapeutics, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$1.10
+0.00%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-152.5%
Return on equity
-124.8%
Return on assets
-162.4%
Return on invested capital
0.00x
Asset turnover
-$17.0M
Cash from operations
$0.15
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026